Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.64 USD | -8.18% | -4.33% | +295.70% |
May. 06 | Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing | MT |
May. 03 | Wall St set to open sharply higher on soft jobs data | RE |
Evolution of the average Target Price on Viking Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Viking Therapeutics, Inc.
Oppenheimer | |
Stifel Nicolaus | |
BTIG | |
Jefferies & Co. | |
HC Wainwright | |
Raymond James | |
Roth MKM | |
Maxim | |
SVB Leerink | |
Vining Sparks |
EPS Revisions
- Stock Market
- Equities
- VKTX Stock
- Consensus Viking Therapeutics, Inc.